Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1Phase 1/2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Uterine Cervical Dysplasia 1Stomatitis 1Rectal Neoplasms 1Pain 1Neurofibromatosis 1 1Lung Neoplasms 1Castration Sensitive Prostate Cancer 1Breast Neoplasms 1Advanced Cancers 1

Interventions

pembrolizumab 82Paclitaxel 71Gemcitabine 66Carboplatin 61Cisplatin 46Docetaxel 44Bevacizumab 41Nivolumab 33Irinotecan 31Fluorouracil 29Pemetrexed 28Cyclophosphamide 26Cetuximab 26Capecitabine 26Erlotinib Hydrochloride 22venetoclax 21trametinib 21Leucovorin 20Sorafenib 17Albumin-Bound Paclitaxel 17Afatinib 17130-nm albumin-bound paclitaxel 17Topotecan 16Radiotherapy 16Oxaliplatin 16fludarabine 15regorafenib 14budigalimab 14atezolizumab 14Ipilimumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms × Curcumin × Clear all
NCT06626230 2026-05-18

Safety of Anal Curcumin

Emory University

Phase 1 Recruiting
48 enrolled
Tumor-Agnostic

Neoplasms

NCT02598726 2025-04-22

Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms in Patients With Cancer

Mayo Clinic

Phase 1 Completed
9 enrolled

Neoplasms, Pain

NCT06044142 2024-08-05

Curcumin VS Photo-bio-modulation Therapy of Oral Mucositis in Pediatric Patients Undergoing Anti-Cancer Non-invasive Treatment

Riyadh Elm University

Phase 1 Completed
90 enrolled

Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡